Helicobacter pyloriEradication with Ecabet Sodium, Omeprazole, Amoxicillin, and Clarithromycin Versus Bismuth, Omeprazole, Amoxicillin, and Clarithromycin Quadruple Therapy: A Randomized, Open-Label, Phase IV Trial-Reference-Cited by-同舟云学术

Helicobacter pyloriEradication with Ecabet Sodium, Omeprazole, Amoxicillin, and Clarithromycin Versus Bismuth, Omeprazole, Amoxicillin, and Clarithromycin Quadruple Therapy: A Randomized, Open-Label, Phase IV Trial

Published:2012-07-02 Issue:6 Volume:17 Page:458-465
ISSN:1083-4389
Container-title:Helicobacter
language:en
Short-container-title:Helicobacter

Author:

Liang Jie¹,Li Jun¹,Han Ying¹,Xia Jielai¹,Yang Yunsheng²,Li Wen²,Zhang Shutian³,Wu Yongdong³,Yuan Yaozong⁴,Li Zhaoshen⁵,Du Yiqi⁵,Chen Minhu⁶,Chen Baili⁶,Jiang Bo⁷,Bai Yang⁷,Wen Qinsheng⁸,Wu Kaichun¹,Fan Daiming¹

Affiliation:

1. Department of Digestive Diseases; Xijing Hospital of Fourth Military Medical University; Xi'an; Shannxi; China

2. Department of Digestive Diseases; China PLA General Hospital; Beijing; China

3. Department of Digestive Diseases; Friendship Hospital of Capital Medical University; Beijing; China

4. Department of Digestive Diseases; Ruijin Hospital of Shanghai Jiaotong University; Shanghai; China

5. Department of Digestive Diseases; Changhai Hospital of Second Military Medical University; Shanghai; China

6. Department of Digestive Diseases; Affiliated No. 1 Hospital of Zhongshan University; Guangzhou; China

7. Department of Digestive Diseases; Nanfang Hospital of Southern Medical University; Guangzhou; China

8. Department of Digestive Diseases; Tangdu Hospital of Fourth Military Medical University; Xi'an; Shannxi; China

Publisher

Wiley

Subject

Infectious Diseases,Gastroenterology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1523-5378.2012.00971.x/fullpdf

Reference43 articles.

1. Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial;Malfertheiner;Lancet,2011

2. Peptic ulcer disease;Malfertheiner;Lancet,2009

3. Prevalence of Helicobacter pylori infection in China;Zhang;Modern digestion and intervention,2010

4. Helicobacter pylori infection;Suerbaum;N Engl J Med,2002

5. Clinical practice. Helicobacter pylori infection;McColl;N Engl J Med,2010

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vonoprazan Dual or Triple Therapy Versus Bismuth‐Quadruple Therapy as First‐Line Therapy for Helicobacter pylori Infection: A Three‐Arm, Randomized Clinical Trial;Helicobacter;2024-09

2. Novel Information Regarding the Treatment of Helicobacter pylori Infection: A Systematic Review and Meta-analysis of Randomized Clinical Trials;Current Reviews in Clinical and Experimental Pharmacology;2024-07

3. Helicobacter pylori antibiotic resistance profile in Chinese children with upper gastrointestinal symptoms and a literature review for developing personalized eradicating strategies;Frontiers in Pharmacology;2024-06-03

4. Is tailored therapy based on antibiotic susceptibility effective ? a multicenter, open-label, randomized trial;Frontiers of Medicine;2020-01-03

5. Combination of Bismuth and Standard Triple Therapy Eradicates Helicobacter pylori Infection in More than 90% of Patients;Clinical Gastroenterology and Hepatology;2020-01